Perceptive Advisors’s Urovant Sciences Ltd. UROV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-3,116,831
| Closed | -$50.3M | – | 171 |
|
|
2020
Q4 | $50.3M | Buy |
3,116,831
+750,000
| +32% | +$12.1M | 0.54% | 46 |
|
|
2020
Q3 | $22.1M | Hold |
2,366,831
| – | – | 0.32% | 62 |
|
|
2020
Q2 | $23.3M | Hold |
2,366,831
| – | – | 0.38% | 55 |
|
|
2020
Q1 | $21.8M | Sell |
2,366,831
-40,100
| -2% | -$370K | 0.57% | 41 |
|
|
2019
Q4 | $37.3M | Buy |
2,406,931
+160,384
| +7% | +$2.49M | 0.74% | 34 |
|
|
2019
Q3 | $21.3M | Buy |
2,246,547
+371,121
| +20% | +$3.51M | 0.57% | 44 |
|
|
2019
Q2 | $14.8M | Buy |
1,875,426
+1,010,067
| +117% | +$7.99M | 0.34% | 55 |
|
|
2019
Q1 | $8.7M | Buy |
865,359
+240,000
| +38% | +$2.41M | 0.25% | 62 |
|
|
2018
Q4 | $3.92M | Buy |
625,359
+162,700
| +35% | +$1.02M | 0.15% | 66 |
|
|
2018
Q3 | $5.55M | Buy |
+462,659
| New | +$5.55M | 0.15% | 69 |
|